Market Research Reports

All Reports Home

Categories

Countries

Pharmaceuticals Reports

Plant Based Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Carbohydrates, Proteins, Polymers, Minerals, Glycoside & Waxes, Esters, Others), By Application (Binders & Diluents, Glidants, Lubricants & Disintegrants, Film Forming & Coating Agents, Plasticizers, Suspending Agents, Others), By Region and Competition, 2020-2030F

Global Plant Based Excipients Market to be driven by growing interest in plant based excipients as an alternative to traditional excipients in pharmaceuticals Read More

Bioelectronic Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type (Implantable, Non-invasive), By Product (Implantable Cardioverter Defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve stimulators, Others), By Application (Arrhythmia, Pain Management, Sensorineural Hearing loss, Parkinson’s disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and Fecal Incontinence, Others), By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others), By Region and Competition, 2020-2030F

The increasing prevalence of chronic disorders is expected to drive the Global Bioelectronic Medicine Market during the forecast period, 2026-2030.Read More

Next Generation Biotherapeutics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Therapeutic Area (Oncology, Autoimmune/ Inflammatory Diseases), By Technology (Antibody-Drug Conjugates, Bispecific Antibodies, Antibody Fragments, Antibody-like Proteins, Others), By Region & Competition, 2020-2030F

Increasing Incidence of Cancer and Rising Prevalence of Autoimmune Diseases are factors driving the Global Next Generation Biotherapeutics market in the forecast Read More

United States Clinical Trial Investigative Site Network Market By Phase (Phase I, Phase II, Phase III, Phase IV), By Therapeutic Area (Oncology, Cardiology, CNS Conditions, Pain Management, Endocrine, Others), By End User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Growing demand for decentralized trials and increasing adoption of real-world evidence in clinical research are the factors driving the United States Clinical Read More

United States CAR-T Cell Therapy Market, By Product (Abecma (idecabtagene vicleucel), Breyanzi (lisocabtagene maraleucel), Carvykti (ciltacabtagene autoleucel), Kymriah (tisagenlecleucel), Tecartus (brexucabtagene autoleucel), Yescarta (axicabtagene ciloleucel), Others), By Disease (Leukemia, Lymphoma, Multiple Myeloma, Others), By End User (Hospitals, Cancer Treatment Centers), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing Incidence of Cancer and Aging Population are factors driving the United States CAR-T Cell Therapy market in the forecast period 2026-2030.Read More

Vietnam Generic Drugs Market, By Type (Small Molecule Generics, Biosimilars), By Mode of Drug Delivery (Oral, Parenteral, Topical, Others), By Form (Tablets, Capsules, Injections, Others), By Source (Contract Manufacturing Organizations, In-house), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), By Application (Neurology, Oncology, Cardiovascular Diseases, Diabetes, Anti-Inflammatory Diseases, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Aging Population and the Rising Prevalence of Chronic Diseases and Growth of Healthcare Infrastructure are factors driving the Vietnam Generic Drugs market in Read More

Saudi Arabia Antibiotics Market By Drug Class (Cephalosporin, Penicillin, Amoxicillin, Azithromycin, Clindamycin, Tetracycline, Others), By Spectrum (Broad Spectrum Antibiotics, Narrow Spectrum Antibiotics), By Source (Natural, Semisynthetic, Synthetic), By Route of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing Hospital-Acquired Infections and Rising Prevalence of Infectious Diseases are expected to drive the demand of Saudi Arabia Antibiotics Market in the Read More

India Pharmaceutical Packaging Market By Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminium Foil, Others), By End User (Pharmaceutical & Biotechnology companies, contract manufacturers, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Expansion of the Pharmaceutical Industry and Technological Advancements in Packaging Materials are factors driving the India Pharmaceutical Packaging market in Read More

Japan Inflammatory Bowel Disease (IBD) Drugs Market By Disease Type (Crohn’s Disease and Ulcerative Colitis), By Drug Class (TNF Inhibitors, JAK Inhibitors, Aminosalicylates, Corticosteroids, and Others), By Route of Administration (Oral and Parenteral), By End User (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing incidence of IBD and advancements in diagnostic technologies are factors driving the Japan Inflammatory Bowel Disease (IBD) Drugs Market in the Read More

Japan Influenza Medications Market By Type (Antiviral Drugs, Antihistamines, Vaccines, Others), By Route of Administration (Oral, Inhaled), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Evolving influenza virus strains and rising incidence of influenza outbreaks are factors driving the Japan Influenza Medications Market in the forecast period Read More

Japan Kidney Cancer Drugs Market By Therapy (Immunotherapy, Chemotherapy, Targeted Therapy), By Drug Class (Monoclonal antibodies, Angiogenesis and mTOR Inhibitors), By Route of Administration (Oral, Intravenous and Subcutaneous), By Distribution Channel (Hospitals, Retail Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising incidence of renal cell carcinoma (RCC) and advancements in targeted therapies & immunotherapies are factors driving the Japan Kidney Cancer Drugs Market Read More

Japan Lipid Lowering Drugs Market, By Drug (Statins & Combination, PCSK9 Inhibitors, Bile Acid Sequestrants, Fibrates, Cholesterol Absorption Inhibitors, Others), By Indication (Hypercholesterolemia, Coronary Artery Disease, High Triglycerides), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Advancements in pharmaceutical research and increasing prevalence of cardiovascular diseases are factors driving the Japan Lipid Lowering Drugs Market in the Read More

India Glass Pharmaceutical Packaging Materials Market, By Product (Ampoules, Bottles, Vials, Syringes, Cartridges, Other), By Material (Type I Glass, Type II Glass, Type III Glass), By Application (Oral Medications, Injectable Medications, Nasal Medications, Other), By Region, Competition, Forecast & Opportunities, 2020-2030F

Booming Pharmaceutical Industry and Technological Advancements in Glass Manufacturing are factors driving the India Glass Pharmaceutical Packaging Materials Read More

Japan Gastrointestinal Drugs Market By Type (Branded and Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, and Others), By Application (Crohn’s Disease, Ulcerative Colitis, GERD, IBS), By Route Of Administration (Oral, Injectable, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increasing availability and acceptance of over-the-counter (OTC) gastrointestinal medications are factors driving the Japan Gastrointestinal Drugs Market in the Read More

Japan Glaucoma Drugs Market By Indication (Open Angle Glaucoma, Angle Closure Glaucoma, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region, Competition, Forecast & Opportunities, 2020-2030F

Increased prevalence of glaucoma, and advancements in drug therapies are factors driving the Japan Glaucoma Drugs Market in the forecast period 2026-2030.Read More

Japan Gynecology Drugs Market By Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), By Indication (Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Expansion of distribution channels and increasing prevalence of gynecological disorders are factors driving the Japan Gynecology Drugs Market in the forecast Read More

Japan Human Insulin Market By Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilars), By Application (Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus), By Type (Human Insulin, Insulin Analog), By Distribution Channel (Hospitals, Retail Pharmacies, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Rising prevalence of diabetes and development of innovative insulin formulations are factors driving the Japan Human Insulin Market in the forecast period Read More

Japan Immunosuppressant Drugs Market By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents, MTOR Inhibitor, Steroids, and Others), By Application (Autoimmune Diseases, Organ Transplant, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F

Innovations in immunosuppressant drug formulations and expanding need for organ transplantation are factors driving the Japan Immunosuppressant Drugs Market in Read More

India Rifampicin Market, By Source (In-house, Contract Manufacturing Organizations), By Form (Tablet, Capsule, Injection), By Route of Administration (Oral, Intravenous), By Distribution Channel (Online, Offline), By Application (Tuberculosis, Leprosy, Legionnaire's Disease, Others), By End User (Adult, Paediatric), By Region, Competition, Forecast & Opportunities, 2020-2030F

High Tuberculosis (TB) Burden and Strong Demand for Fixed-Dose Combination (FDC) Therapies are factors driving the India Rifampicin market in the forecast period Read More

Indonesia Regenerative Medicine Market By Type (Cell Therapy, Gene Modification, Tissue Engineering, Others), By Application (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular Diseases, Others), By End User (Academic Institutions and Hospitals & Clinics), By Region, Competition, Forecast and Opportunities, 2020-2030F

Rising Prevalence of Chronic Diseases and Aging Population are factors driving the Indonesia Regenerative Medicine Market in the forecast period, 2026-2030.Read More

Prev    Page 21 of 30 Next